BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23281287)

  • 1. Concentrations of Gd-BOPTA in cholestatic fatty rat livers: role of transport functions through membrane proteins.
    Pastor CM; Wissmeyer M; Millet P
    Contrast Media Mol Imaging; 2013; 8(2):147-56. PubMed ID: 23281287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How organic anions accumulate in hepatocytes lacking Mrp2: evidence in rat liver.
    Millet P; Moulin M; Stieger B; Daali Y; Pastor CM
    J Pharmacol Exp Ther; 2011 Mar; 336(3):624-32. PubMed ID: 21131269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver Perfusion Modifies Gd-DTPA and Gd-BOPTA Hepatocyte Concentrations Through Transfer Clearances Across Sinusoidal Membranes.
    Daire JL; Leporq B; Vilgrain V; Van Beers BE; Schmidt S; Pastor CM
    Eur J Drug Metab Pharmacokinet; 2017 Aug; 42(4):657-667. PubMed ID: 27778300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of gadobenate dimeglumine in isolated perfused rat liver: MR imaging evaluation.
    Pastor CM; Planchamp C; Pochon S; Lorusso V; Montet X; Mayer J; Terrier F; Vallee JP
    Radiology; 2003 Oct; 229(1):119-25. PubMed ID: 12944603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How transfer rates generate Gd-BOPTA concentrations in rat liver compartments: implications for clinical liver imaging with hepatobiliary contrast agents.
    Pastor CM
    Contrast Media Mol Imaging; 2016 Jul; 11(4):291-8. PubMed ID: 27060676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steatosis Alters the Activity of Hepatocyte Membrane Transporters in Obese Rats.
    Pastor CM; Vilgrain V
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gd-BOPTA transport into rat hepatocytes: pharmacokinetic analysis of dynamic magnetic resonance images using a hollow-fiber bioreactor.
    Planchamp C; Gex-Fabry M; Dornier C; Quadri R; Reist M; Ivancevic MK; Vallée JP; Pochon S; Terrier F; Balant L; Stieger B; Meier PJ; Pastor CM
    Invest Radiol; 2004 Aug; 39(8):506-15. PubMed ID: 15257212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolated Perfused Rat Livers to Quantify the Pharmacokinetics and Concentrations of Gd-BOPTA.
    Pastor CM
    Contrast Media Mol Imaging; 2018; 2018():3839108. PubMed ID: 30116162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of Gd-BOPTA uptake and biliary excretion from dynamic magnetic resonance imaging in rat livers: model validation with 153Gd-BOPTA.
    Planchamp C; Pastor CM; Balant L; Becker CD; Terrier F; Gex-Fabry M
    Invest Radiol; 2005 Nov; 40(11):705-14. PubMed ID: 16230903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Model-based analysis of Gd-BOPTA-induced MR signal intensity changes in cirrhotic rat livers.
    Planchamp C; Gex-Fabry M; Becker CD; Pastor CM
    Invest Radiol; 2007 Jul; 42(7):513-21. PubMed ID: 17568274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct evidence of the temperature dependence of Gd-BOPTA transport in the intact rat liver.
    Planchamp C; Beyer GJ; Slosman DO; Terrier F; Pastor CM
    Appl Radiat Isot; 2005 Jun; 62(6):943-9. PubMed ID: 15799874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of Pharmacokinetic Modeling to Characterize Hepatobiliary Disposition of Imaging Agents and Alterations due to Liver Injury in Isolated Perfused Rat Livers.
    Jeong A; Pastor CM; Brouwer KLR
    Pharm Res; 2023 Nov; 40(11):2513-2523. PubMed ID: 37349653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gadobenate dimeglumine 0.5 M solution for injection (MultiHance) as contrast agent for magnetic resonance imaging of the liver: mechanistic studies in animals.
    de Haën C; La Ferla R; Maggioni F
    J Comput Assist Tomogr; 1999 Nov; 23 Suppl 1():S169-79. PubMed ID: 10608413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging with hepatospecific contrast agents in cirrhotic rat livers.
    Planchamp C; Montet X; Frossard JL; Quadri R; Stieger B; Meier PJ; Ivancevic MK; Vallée JP; Terrier F; Pastor CM
    Invest Radiol; 2005 Apr; 40(4):187-94. PubMed ID: 15770136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of drug transport function across the multiple resistance-associated protein 2 (Mrp2) in rat livers.
    Bonnaventure P; Pastor CM
    Int J Mol Sci; 2014 Dec; 16(1):135-47. PubMed ID: 25547484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocyte Concentrations of Imaging Compounds Associated with Transporter Inhibition: Evidence in Perfused Rat Livers.
    Bonnaventure P; Cusin F; Pastor CM
    Drug Metab Dispos; 2019 Apr; 47(4):412-418. PubMed ID: 30674615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Pharmacokinetic Parameters of Imaging Substrates Quantified from Rat Liver Compartments.
    Pastor CM; Brouwer KLR
    Drug Metab Dispos; 2022 Jan; 50(1):58-64. PubMed ID: 34670777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of gadobenate dimeglumine and gadopentetate dimeglumine: a study of MR imaging and inductively coupled plasma atomic emission spectroscopy in rat brain tumors.
    Zhang T; Matsumura A; Yamamoto T; Yoshida F; Nose T; Shimojo N
    AJNR Am J Neuroradiol; 2002 Jan; 23(1):15-8. PubMed ID: 11827870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Function of both sinusoidal and canalicular transporters controls the concentration of organic anions within hepatocytes.
    Planchamp C; Hadengue A; Stieger B; Bourquin J; Vonlaufen A; Frossard JL; Quadri R; Becker CD; Pastor CM
    Mol Pharmacol; 2007 Apr; 71(4):1089-97. PubMed ID: 17234897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of drug-drug interactions through uptake and efflux transport systems in rat hepatocytes: implications for cellular concentrations of competing drugs.
    Daali Y; Millet P; Dayer P; Pastor CM
    Drug Metab Dispos; 2013 Aug; 41(8):1548-56. PubMed ID: 23708009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.